Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site

Services Research Outcomes Study (SROS)

Previous Page TOC Next Page


  1. COMPARISON OF SROS AND OTHER STUDIES

COMPARISON OF SROS AND OTHER STUDIES

Research on the effectiveness of drug treatment has generally focused on samples of individuals from purposively selected, publicly funded facilities. Such studies include the following:

·510·Drug Abuse Reporting Program (DARP) (Sells and Simpson, 1974, 1979, 1981), which followed a cohort of 4,100 clients admitted to treatment during 1969–1972 with two interviews, including a 12-year followup of 700 opioid users who entered treatment from 1969 to 1972;·510

·510·Treatment Outcome Prospective Study (TOPS) (Hubbard et al., 1989), which followed 10,000 clients admitted to 41 drug treatment programs in 10 cities from 1979 to 1981; ·510

·510·Drug Abuse Treatment Outcome Study (DATOS) (Hubbard et al., forthcoming), which followed a purposive sample of 10,000 clients admitted to 99 treatment facilities in 11 cities in the 1990s and interviewed about 3,000 clients one year after discharge from treatment; and·510

·510·National Treatment Improvement Evaluation Study (NTIES) (Gerstein et al., 1997), which followed 6,600 clients treated in a Federal demonstration program and analyzed outcome data for 4,400 clients.·510

DSRS and the California Drug and Alcohol Treatment Assessment (CALDATA) are unusual because they used a probability sample of facilities and individuals. In 1990, DSRS abstracted records for a random sample of 2,222 individuals discharged from drug treatment in the United States between September 1, 1989, and August 31, 1990. In 1992, CALDATA abstracted records for a random sample of 3,055 individuals discharged from drug treatment in California, interviewing 1,826 of them to compare their behavior one year before and one year after treatment.

SROS builds on both of these studies. The SROS sample of discharges includes 1,706 of the 2,222 DSRS discharges (77 percent) plus an additional 1,341 discharges randomly sampled from 32 of the larger facilities to make the SROS sample more nationally representative of clients discharged from treatment — the DSRS sample being based on 20 clients from every facility.

Table 2-4 compares the distribution of clients in SROS and three other significant surveys conducted around the same time period: the 1993–1994 NTIES; the 1991–1993 DATOS; and DSRS, which drew a stratified national probability sample of 120 programs and abstracted treatment records for clients discharged during 1989–1990.

Of these surveys, NTIES and DATOS are purposive surveys; DSRS and SROS are probability samples. The NTIES sample was selected within a framework of competitive award recipients seeking to innovate in their clinical activities; the DATOS sample was selected from standard, stable treatment facilities. DSRS and SROS were intended to represent the national population of facilities and clients.

The samples differ in a number of other respects as well. For example, about 25 percent of NTIES clients were in correctional settings, that were not included in any of the other sample frames. Five percent of SROS clients were in outpatient methadone versus 15 percent of DATOS clients and five percent of DSRS clients. Thirty-seven percent of SROS’ weighted national estimate of clients were discharged from hospital inpatient clinics, whereas only 16 percent of DSRS’ national estimate of clients were hospital inpatients; SROS estimates that 18 percent of national discharges were from residential treatment versus 26 percent projected by DSRS. These differences are likely due to the different classification methods of the two studies. DSRS classified clients according to the predominant modality of the facility as well as the client’s record at the facility while SROS used the client’s statement about modality. In addition, 26 percent of the DSRS national estimate was attributed to discharges from facilities with mixed modes (e.g., alcohol and others).

 

Table 2-4. Distribution of Clients by Modality in NTIES, DATOS, DSRS, and SROS


NTIES 1993-94

DATOS 1991-93

DSRS 1989-90

SROS 1989-90


Admissions Sample

Admissions Sample

Discharge Sample

Weighted National Estimate of Annual Discharges

Responding Clients

Weighted National Estimates of Discharges


Number

Percent

Number

Percent

Number

Percent

Percent

Number

Percent

Number

Percent

Outpatient

Methadone

514

8

1,540

15

292

13

5

217

12

47,871

5

Outpatient Nonmethadone

2,107

32

2,574

26

500

23

27

556

31

387,375

40

Hospital Inpatient

1,209

18

3,122

31

421

19

16

700

39

357,954

37

Residential

1,109

17

2,774

28

496

23

26

326

18

173,811

18

Correctional

Mixed Modes (alcohol only, unknown)

1,654

25



473

22

26





Total

6,593

100

10,010

100

2,182

100

100

1,799

100

967,012

100

NOTE: The components of the DSRS mixed modes are described in Table 2-1.








III. FINDINGS

Previous Page Page Top TOC Next Page

Go to SAMHSA Home Page

Click to Return to OAS Home Page 

 Click to Email OAS Data Questions 

  Click For Non-frames / text version of site

This page was last updated on April 29, 2004.

SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.

            Privacy Statement  |  Site Disclaimer  |   Accessibility